Gastrointestinal Stromal Tumors

Some of the drugs in the pipeline for colorectal cancer therapeutics are Lonsurf, CYRAMZA (ramucirumab), TS-1/Teysuno, CPP-1X (eflornithine hydrochloride), MelCancerVac, Xilonix, and Nintedanib. There are various medications such as chemotherapy drugs, immunotherapy, and leucovorin (chemoprotectant) that can be used to treat colorectal cancer. Chemotherapy drugs for the treatment of colorectal cancer include anti-metabolites such as fluorouracil and capecitabine. Monoclonal antibodies used in immunotherapy as part of the treatment of colorectal cancer are bevacizumab, cetuximab, and panitumumab. Bevacizumab (Avastin®), ramucirumab (Cyramza®), and ziv-aflibercept (Zaltrap®) are drugs used for colon cancer that target vascular endothelial growth factor (VEGF). VEGF is a protein that helps tumors form new blood vessels to get nutrients (a process known as angiogenesis).

Analysis from business intelligence provider GBI Research - Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - states that the Colorectal Cancer (CRC) treatment market value will increase at a moderate Compound Annual Growth Rate (CAGR) of 1.8%, from $8.3 billion in 2013 to $9.4 billion by 2020.Bevacizumab and ramucirumab are monoclonal antibodies, which are man-made versions of immune system proteins. These drugs are typically combined with chemo to treat advanced colon cancer.
 
Ziv-aflibercept is a different kind of protein that targets VEGF. It can also be combined with chemo to treat advanced colon cancer, although it was approved to be combined only with a certain chemo combination.These drugs are given as infusions into a vein (IV) every 2 or 3 weeks.
 
 
  • Drugs used for Pancreatic & Colorectal Cancer
  • Current therapeutic approaches
  • Novel therapeutic antibodies to treat colorectal cancer
  • Colorectal Cancer Therapeutics Market: Global Industry Analysis
  • Adverse drug reactions

Related Conference of Gastrointestinal Stromal Tumors

November 20-22, 2017

14th Asia Pacific
Oncologists Annual Meeting

Melbourne, Australia
November 27-28, 2017

26th World Cancer Convention

Dubai, UAE
November 27- 28, 2017

International Conference on Cancer Diagnostics

Dubai, UAE
December 07-08, 2017

9th World Biomarkers Congress

Madrid, Spain
October 03-04, 2018

26th Annual Congress on Cancer Science and Therapy

Los Angeles, California, USA
March 12-14, 2018

Global Summit on Oncology & Cancer

Singapore
May 24-25, 2018

22nd Global Annual Oncologists Meeting

Osaka, Japan
June 1-2, 2018

Global Meeting on Oncology and Radiology

Osaka,Japan
July 2-3, 2018

World Cancer Summit 2018

Thailand, Bangkok
July 18-19, 2018

4th Annual Conference on Preventive Oncology

Atlanta, USA
July 18-19, 2018

4th Annual Conference on Gynecologic Oncology

Atlanta, USA
July 23-24, 2018

Experts Meet On Cancer Therapy 2018

Melbourne, Australia
July 23-24, 2018

International Conference on Cancer Therapy

Osaka, Japan
August 09-10, 2018

28th Euro Congress on Cancer Science & Therapy

Madrid, Spain

World Cancer Meeting

Osaka, Japan
September 20-21, 2018

3rd Oncologist & Cancer Diagnostics Conference 2018

Berlin, Germany
October 03-04, 2018

2nd International Conference on Cancer Biology and Drug Delivery

Los Angeles, California, USA
October 03-04, 2018

12th World Congress on Biomarkers & Clinical Research

Los Angeles, California, USA
October 15-16, 2018

22nd World Conference onLiquid Biopsy & Biomarkers

Toronto, Canada
October 18-19, 2018

Euro Oncology Summit 2018

Amsterdam, Netherlands
October 11-13, 2018

36th World Cancer Conference

Zurich, Switzerland
October 26-27, 2018

International Conference on Robotic Oncology

Osaka, Japan
November 07-08, 2018

Cancer

San Francisco, USA
December 07-08, 2018

27th World Oncologist Annual Conference

Chicago, Illinios, USA

Gastrointestinal Stromal Tumors Conference Speakers

Recommended Sessions

Related Journals

Are you interested in